Regado BioSciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development 26,542 8,006
Sales, General and Admin. 7,297 4,157
Non-Recurring Items - -
Other - -
Operating Income (33,839) (12,163)
Income From Continuing Operations
Add'l Income/Expense Items 80 5
Earnings Before Interest and Tax (33,759) (12,158)
Interest Expense 680 904
Earnings Before Tax (34,439) (13,062)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (34,439) (13,062)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (34,439) (13,062)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (34,439) (13,062)